Clinical Trial Update: Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating darolutamide with consolidation radiotherapy in advanced PSMA-detected prostate cancer; the study is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Darolutamide (darolutamide)

Snippet

Sponsor: Trans Tasman Radiation Oncology Group | Conditions: Advanced Prostate Carcinoma, Cancer of Prostate | Phase 2 | Status: ACTIVE_NOT_RECRUITING